Evan Newell

University of Washington - Department of Laboratory Medicine and Pathology

SCHOLARLY PAPERS

2

DOWNLOADS

78

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Distinct Tumor-Resident Memory HBV-Specific T Cell Responses Correlate with Relapse-Free Survival in Patients with HBV-Associated Hepatocellular Carcinoma

Number of pages: 96 Posted: 05 Jan 2021
Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, St Jude Children’s Research Hospital - Department of Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, St Jude Children’s Research Hospital - Department of Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, KK Women’s and Children’s Hospital - Department of Reproductive Medicine, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Cancer Centre Singapore - Division of Medical Oncology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National University Health System (NUHS) - Division of Gastroenterology and Hepatology, Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, National Cancer Centre Singapore - Division of Medical Oncology and University of Washington - Department of Laboratory Medicine and Pathology
Downloads 49 (759,350)

Abstract:

Loading...

2.

Circulating Cancer-Specific CD8 T Cell Frequency Associates with Response to Pd-1 Blockade in Merkel Cell Carcinoma

Number of pages: 1054 Posted: 21 Jul 2023
University of Washington - Division of Dermatology, University of Washington - Division of Dermatology, University of Washington - Department of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Johns Hopkins University - Bloomberg-Kimmel Institute for Cancer Immunotherapy, University of Washington - Division of Dermatology, University of Washington - Division of Dermatology, Bristol Myers Squibb, Fred Hutchinson Cancer Research Center - Clinical Research Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Providence-Swedish Cancer Institute - Paul G Allen Research Center, Johns Hopkins University - Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University - Bloomberg-Kimmel Institute for Cancer Immunotherapy, University of Washington - Department of Laboratory Medicine and Pathology, University of Washington - Department of Laboratory Medicine and Pathology, Johns Hopkins University - Bloomberg-Kimmel Institute for Cancer Immunotherapy, University of Washington - Division of Dermatology and Independent
Downloads 29 (914,782)

Abstract:

Loading...

Merkel cell carcinoma, Merkel cell polyomavirus, cancer-specific T cells, skin cancer, anti-PD-1, primary resistance, acquired resistance, nivolumab, HLA-I